VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 139 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,657,287 | +198.1% | 108,037 | +362.3% | 0.01% | +160.0% |
Q2 2023 | $555,900 | -39.4% | 23,367 | -25.6% | 0.01% | -37.5% |
Q4 2022 | $917,194 | -2.9% | 31,400 | -40.3% | 0.01% | 0.0% |
Q3 2022 | $945,000 | +122.4% | 52,623 | +144.6% | 0.01% | +100.0% |
Q4 2021 | $425,000 | -41.3% | 21,512 | -51.1% | 0.00% | -42.9% |
Q3 2021 | $724,000 | – | 44,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 944,092 | $15,530,000 | 5.65% |
Ally Bridge Group (NY) LLC | 904,978 | $14,887,000 | 4.38% |
COMMODORE CAPITAL LP | 667,674 | $10,983,000 | 2.90% |
FRAZIER MANAGEMENT LLC | 1,505,200 | $24,761,000 | 1.98% |
Logos Global Management LP | 1,500,000 | $24,675,000 | 1.78% |
Ghost Tree Capital, LLC | 350,000 | $5,758,000 | 1.68% |
SILVERARC CAPITAL MANAGEMENT, LLC | 106,078 | $1,745,000 | 0.99% |
Vivo Capital, LLC | 1,300,000 | $21,385,000 | 0.96% |
ACUTA CAPITAL PARTNERS, LLC | 135,807 | $2,234,000 | 0.79% |
BVF INC/IL | 804,126 | $13,228,000 | 0.52% |